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Unlike hydrophobic maleimides, eosin-5-maleimide and to a lesser extent other relatively polar maleimides inhibit the 
2-oxoglutarate carrier of bovine heart mitochondria. The impermeable eosin-5maleimide labels the 2-oxoglutarate carri- 
er in intact mitochondria but not in submitochondrial particles. 2-Oxoglutarate protects the carrier against inactivation 
by eosin-5-maleimide and decreases the fluorescence associated with the purified protein. Other anions which are not 
substrates of the carrier have no protective effect. It is concluded that sulthydryl groups essential for the activity of the 
2-oxoglutarate carrier are located at the cytosolic face of the inner mitochondrial membrane. They appear to be present 
at the substrate-binding site and located in a hydrophilic environment. 
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1. INTRODUCTION 
The 2-oxoglutarate carrier catalyzes the 
transport of 2-oxoglutarate through the inner 
mitochondrial membrane by a strict 1 : 
counterexchange 
[l-3], 
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Mitochondria and inside-out submitochondrial particles 
from bovine heart were prepared as described in [7,8], respec- 
tively. Solubilization of mitochondria and submitochondrial 
particles, purification of the OGC by hydroxyapatite/celite 
chromatography and reconstitution of the hydroxy- 
apatite/celite eluate in liposomes prepared in the presence of 
1 mM 2-oxoglutarate were carried out as described previously 
[2,3]. The proteoliposomes were incubated with the indicated 
maleimides in 20 mM NaCl, 10 mM Pipes, 1 mM 
2-oxoglutarate and 1 mM EDTA, pH 7.0. After 3 min at 25”C, 
the reaction was stopped by the addition of 10 mM 
dithioerythritol. After a further 2 min, transport was initiated 
by adding carrier-free [r‘C]oxoglutarate and terminated 8 min 
later by the addition of 10 mM phthalonate, a powerful in- 
hibitor of the OGC. In the control samples phthalonate was 
added together with the labelled substrate at time zero. The ac- 
tivity was calculated by subtracting the control values from the 
experimental samples [9]. 
Modification of the OGC by maleimides in freshly prepared 
mitochondria or submitochondrial particles was performed at 
0°C in a medium containing 250 mM sucrose, 1 mM EGTA 
and 10 mM Tris-HCl, pH 7.4, at a protein concentration of 
10 mg/ml with 250 pM EMA for 45 min in the dark. The reac- 
tion was terminated by the addition of 10 mM dithioerythritol. 
After an additional 2 min the labelled membranes were washed 
twice in the same medium. The OGC was then purified from 
both mitochondria and submitochondrial particles and the ac- 
tivity of 2-oxoglutarate transport was measured in reconstituted 
liposomes. 
Polyacrylamide slab gel electrophoresis was performed as in 
[2]. After electrophoresis, fluorographs were obtained by il- 
luminating the slab gel with UV light and photographing the 
fluorescent emission through cutoff filters. Subsequently, the 
gel was stained by the silver nitrate method [lo]. Protein was 
determined by the Lowry method modified for the presence of 
Triton [ll]. Clutathione was determined as in [12]. 
3. RESULTS 
The effects of N-ethylmaleimide and EMA on 
the reconstituted oxoglutarate/oxoglutarate ex- 
change activity are shown in fig.1. Whereas N- 
ethylmaleimide did not significantly inhibit the 
OGC protein, EMA was a powerful inhibitor of 
oxoglutarate transport in proteoliposomes. Thus, 
half-maximal inhibition was achieved with 26 yM 
EMA. In other experiments (not shown) the effec- 
tiveness of other maleimides in inhibiting the 
reconstituted oxoglutarate transport activity was 
tested. Like N-ethylmaleimide, the hydrophobic 
N-phenylmaleimide and N-cyclohexylmaleimide 
had very little, if any, inhibitory effect. The 
relatively polar 4-maleimidylsalicylic acid, 
5-maleimidylsalicylic acid and N-(4-dimethyl- 
amino-3,5-dinitrophenyl)maleimide inhibited oxo- 
glutarate transport to some extent (27-45% at a 
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Fig.2. Differing ability of EMA In labehng SH groups of the OGC in mitochondria and in submitochondrial particles. SDS- 
polyacrylamide gel electrophoresis (A) and fluorography (B) of Triton X-l 14 extracts obtained from mitochondria (lanes 2) or from 
submitochondrial particles (lanes 4), and of the purified OGC obtained from EMA-labelled mitochondria (lanes 3) or from EMA- 
labelled submitochondrial particles (lanes 5). C shows the fluorography of the purified OGC obtained from intact mitochondria 
incubated with EMA in the presence (lane 7) and absence (lane 6) of 5 mM oxoglutarate. In lane 8, 5 mM 2-oxoadipate was present 
instead of oxoglutarate. Marker proteins (bovine serum albumin, carbonic anhydrase, cytochrome c) are shown in lanes I. 
belled by EMA, the OGC protein was isolated 
from both intact mitochondria and submitochon- 
drial particles pretreated with 250 ,uM EMA. As 
shown in fig.2B, lane 3, the OGC isolated from 
mitochondria was labelled by EMA. In contrast, 
no labelling of the OGC isolated from sub- 
mitochondrial particles was observed (fig.2B, lane 
5). Accordingly the activity of the reconstituted 
OGC isolated from EMA-labelled mitochondria 
was inhibited by 75%, whereas that of the carrier 
derived from EMA-labelled submitochondrial par- 
ticles was not affected (not shown). Increasing the 
concentration of EMA to 1 mM and the time of in- 
cubation to 60 min also failed to induce labelling 
of OGC in submitochondrial particles; the la- 
belling of the carrier protein in mitochondria, on 
the other hand, was time- and concentration- 
dependent (not shown). 
In order to obtain information on the site of the 
OGC to which EMA binds, the effect of ox- 
oglutarate on inactivation and labelling of the 
OGC by EMA in intact mitochondria was in- 
vestigated. Fig.3 shows that the inhibition of ox- 
oglutarate transport activity by 250 ,xM EMA was 
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Fig.3. Effect of oxoglutarate and 2-oxoadipate on the inhibition 
of the OGC by EMA in intact mitochondria. Oxoglutarate (0) 
or 2-oxoadipate (0) was present at the concentrations 
indicated during the incubation of the mitochondria with 
250pM EMA. The activity was measured in liposomes 
reconstituted with purified OGC. 
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progressively decreased by the presence of increas- 
ing concentrations of oxoglutarate during the in- 
cubation of the mitochondria with EMA. 5 mM 
oxoglutarate nearly completely protected the OGC 
against inhibition by EMA. The specificity of the 
protection of the OGC against EMA inactivation 
was investigated by testing the effect of several 
other anions. As shown in fig.3, 2-oxoadipate up 
to 15 mM had no protective effect. Similarly 
glutarate, 2-oxomalonate, ADP, citrate, sulphate 
and phosphate had virtually no effect on the in- 
hibition of the OGC by EMA (not shown). In con- 
trast, malate and malonate, which are known 
substrates of the OGC [6], caused a significant 
protection. The observed protection by ox- 
oglutarate against inhibition by EMA was accom- 
panied by a decreased labelling of the carrier. Thus 
no fluorescence associated with the OGC purified 
from EMA-labelled mitochondria was observed 
when 5 mM oxoglutarate was present during the 
incubation of the mitochondria with EMA (fig.2C, 
cf. lane 7 with 6). In the presence of 2-oxoadipate, 
on the other hand, the intensity of the label bound 
to the OGC was not reduced (fig.2C, lane 8). 
4. DISCUSSION 
The results presented in this paper show that, 
unlike N-ethylmaleimide, the highly polar EMA 
strongly inhibits the OGC of bovine heart 
mitochondria. The extent of inhibition caused by 
the maleimides tested seems to correlate with their 
hydrophilicity since the relatively polar N- 
(4-dimethylamino-3,5dinitrophenyl)maleimide 
and salicilylmaleimides also cause some inactiva- 
tion of the OGC, whereas the hydrophobic 
maleimides have no effect. These results are in 
contrast to the effect of maleimides on the 
phosphate and the ADP/ATP carrier which are in- 
hibited by both N-ethylmaleimide and EMA 
[ 13- 151. The differential behaviour of the OGC 
towards polar and apolar maleimides, respectively, 
suggests that the environment of the essential 
sulfhydryl groups of the OGC has a hydrophilic 
character. 
The fact that the impermeable SH-binding 
reagent EMA inhibits and labels the OGC in intact 
mitochondria, but not in submitochondrial par- 
ticles, clearly indicates that the essential EMA- 
reacting SH groups of the OGC are located at the 
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cytosolic face of the inner mitochondrial mem- 
brane. This asymmetry of the OGC seems to be 
preserved even after reconstitution of the protein 
into the liposomes, since EMA also almost com- 
pletely inhibits the reconstituted carrier (fig.1). In 
intact mitochondria the OGC activity is completely 
inhibited by 0.5 mM EMA (not shown). 
Another structural feature of the OGC can be 
derived from the experiments presented in this 
paper. Oxoglutarate protects the OGC from in- 
hibition and labelling by EMA whereas other 
anions, which are not substrates of the OGC, show 
no protective effect. These results can be inter- 
preted to indicate that the SH groups reacting with 
EMA are located in the vicinity of the substrate- 
binding site. 
In conclusion, EMA appears to be a suitable 
tool for the characterization of essential sulfhydryl 
groups present at, or near, the substrate-binding 
site of the OGC, which faces the cytosol. Ex- 
periments are now in progress to locate the EMA- 
reacting site(s) within the amino acid sequence of 
the OGC. 
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